JAN 31, 2018 10:02 AM PST

Erectile Function Not Impacted by Heart Meds

WRITTEN BY: Kara Marker

Erectile dysfunction (ED) is often believed by men to be a side effect of drugs prescribed to treat high blood pressure and high cholesterol, which promote the development of heart disease. But a new study from scientists at McMaster University in Canada examining the effects of such drugs finds that men taking them have nothing to worry about.

As men grow older, ED become more common. It affects 40 percent of men older than 50 and can be a sign of health problems like vascular disease or nerve damage from diabetes. For men with both ED and heart disease risk factors like high blood pressure and high cholesterol, the idea that the medications they take to treat these risk factors are causing their ED is apparently a misconception.

"Previous research suggests that cardiovascular risk factors such as high blood pressure and cholesterol increase the risk of ED, but there has been little research examining whether modifying these risk factors can impact its development," explained lead investigator Philip Joseph, MD.

In Joseph’s new study, he examined the impact of statins, which lower cholesterol, and a combination drug called candesartan/Hydrochlorothiazide (HCTZ), which lower blood pressure, on erectile function. HCTZ is a diuretic drug (it prevents too much salt absorption) and candesartan is an “angiotensin II receptor antagonist” which means that it improves blood flow by preventing narrowing of the blood vessels. Together, these two drugs treat high blood pressure.

Researchers conducted their study in two thousand men with three experimental groups: men taking a drug called rosuvastatin to lower cholesterol, men taking candesartan/HCTZ to lower blood pressure, and men taking both. Each group was compared to its own placebo control group. The control groups were given placebos - pills with no actual medication in them - to factor in a phenomenon that sometimes occurs, the placebo effect. This is where study subjects taking a placebo feel like they are getting better or having a desirable effect because they believe they are taking medicine. Neither the study subjects nor the study researchers knew which participants received the placebo and which received the actual drugs.

Each participant filled out an erectile function questionnaire, “The International Index of Erectile Function,” which is a validated survey to assess erectile function. They completed the questionnaire at the beginning of the study and after an average follow-up of about six years.

The results were straightforward; none of the men taking any combination of drugs reported a significant change in erectile function compared to each placebo control group.

"Men who develop ED while on such medications commonly attribute their symptoms to the medications,” Joseph said. “Our findings suggest that these two medications do not negatively impact erectile function, which should be reassuring to men who are taking them."

The present study was published in the Canadian Journal of Cardiology.

Sources: Everyday Health, MedlinePlus.gov, Elsevier

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 06, 2020
Cardiology
A New Heart Drug Taken from a Yellow Dye
OCT 06, 2020
A New Heart Drug Taken from a Yellow Dye
Cardiovascular disease is an ever-present issue in the modern world.  One of the most unfortunate cardiovascular ev ...
DEC 29, 2020
Clinical & Molecular DX
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
DEC 29, 2020
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
The statistics are a real eye-opener: in the United States, one person dies every 36 seconds from cardiovascular disease ...
JAN 12, 2021
Cardiology
SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin
JAN 12, 2021
SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin
One of the biggest problems that come alongside diabetes is the increased risk of cardiovascular disease. Treatment of d ...
FEB 18, 2021
Cardiology
Ongoing Heart Problems in Discharged COVID-19 Patients
FEB 18, 2021
Ongoing Heart Problems in Discharged COVID-19 Patients
About 50 percent of patients that are discharged from the hospital after recovering from a severe case of COVID-19 who e ...
MAR 24, 2021
Cardiology
Supplement Can Prevent Strokes in Patients with Rare Disease
MAR 24, 2021
Supplement Can Prevent Strokes in Patients with Rare Disease
Scientists have found that it may be possible for people with a rare genetic disorder to prevent fatal strokes by taking ...
APR 27, 2021
Cardiology
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
APR 27, 2021
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
The heart is one of the most reliable parts of the body. It pumps day and night, delivering fresh oxygen and nutrients t ...
Loading Comments...